← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Ingredion's revenue declined, but higher profit and margins and positive free cash flow showed better mix and cost control beneath the top-line contraction.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 2.8%Watch
- Profitability — Net income grew 12.7% to $729M from $647MOK
- Cash flow — Free cash flow declined 55.2% to $511M from $1.141BWatch
- Margins — Operating margin expanded 219 bps to 14.07%OK
- Accounting — Margin improvement through lower revenueNote
- Insiders — 0 purchases and 10 salesWatch
Business
Ingredion produces starches, sweeteners, texturizers and other ingredients from corn and plant-based raw materials.
Where the revenue comes from
Fiscal 2025, as Ingredion Inc reports it. History and quarterly detail are in the app.
- T&HS$2.4B
- F&II–LATAM$2.4B
- F&II–U.S./Canada$2.1B
Leadership changes
From Ingredion Inc's own filings, the day they're filed.
- James D. Gray · Chief Financial Officer · departureeff. 2026-04-01
- James Gray · Chief Financial Officer · departureeff. 2026-03-31
- Ingredion Incorporated · Chief Financial Officer · departureeff. 2026-03-31
Latest filings
- 8-K · Company announcement2026-08-20
- 10-Q · Quarterly report2026-08-07
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-07-28
- 8-K · Company announcement2026-07-06
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Ingredion Inc, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.